期刊
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
卷 5, 期 2, 页码 199-218出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ECP.12.8
关键词
adenosine; atherosclerosis; cardiac arrhythmias; cardiac remodeling; ischemia-reperfusion injury
资金
- ZonMw [90700354 [40-00703-97-354]]
- Dutch Heart Foundation [2006T035]
Adenosine receptor stimulation has negative inotropic and dromotropic actions, reduces cardiac ischemia-reperfusion injury and remodeling, and prevents cardiac arrhythmias. In the vasculature, adenosine modulates vascular tone, reduces infiltration of inflammatory cells and generation of foam cells, and may prevent the development of atherosclerosis as a result. Modulation of insulin sensitivity may further add to the anti-atherosclerotic properties of adenosine signaling. In the kidney, adenosine plays an important role in tubuloglomerular feedback and modulates tubular sodium reabsorption. The challenge is to take advantage of the beneficial actions of adenosine signaling while preventing its potential adverse effects, such as salt retention and sympathoexcitation. Drugs that interfere with adenosine formation and elimination or drugs that allosterically enhance specific adenosine receptors seem to be most promising to meet this challenge.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据